Kelly M. Brady
Chief Tech/Sci/R&D Officer presso SERES THERAPEUTICS, INC.
Profilo
Kelly M.
Brady is currently the Vice President-Clinical Operations at Seres Therapeutics, Inc. She previously worked as a Senior Director at Akebia Therapeutics, Inc. and as a Member-Operations Team at Osiris Therapeutics, Inc. Ms. Brady holds a graduate degree from The Johns Hopkins University and an undergraduate degree from Lafayette College.
Posizioni attive di Kelly M. Brady
| Società | Posizione | Inizio |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2018 |
Precedenti posizioni note di Kelly M. Brady
| Società | Posizione | Fine |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Kelly M. Brady
| The Johns Hopkins University | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
- Borsa valori
- Insiders
- Kelly M. Brady
